drugset / Trial / NCT00249379
Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees
Phase 4
Terminated
26 enrolled
Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to test how tolerable and effective acamprosate is when used to prevent alcohol relapse in criminal justice supervisees (those on probation, parole, or in drug court).
Timeline
- Start
- 2005-06
- Primary completion
- 2008-08
- Completion
- 2008-08
Outcome
Outcome not reported
Stopped (Enrollment): “Not enough sugjects enrolled before funding ran out”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acamprosate | Small molecule | 333 mg | — |